12/10 message1 Nov 2018 09:30
On 12 Oct 2018, at 10:32, ImmuPharma Investors <investors@immupharma.com> wrote:
Hi ......
Yes we are still in a closed period
We hope to name our service provider working on the Managed Access Programme for Lupuzor(tm) in the next few weeks - this will be important as its again confirms our confidence in Lupuzor and its longer term potential to treat lupus patients
Many Thanks
Lisa